We are live on ! Find out more
PVCT

PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT

Delisted

PVCT was delisted on the 13th of October, 2016.

Back to rankings

6 hedge funds and large institutions have $32.7K invested in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more capital invested

Capital invested by funds: $21.9K → $32.7K (+$10.9K)

14% less funds holding

Funds holding: 7 → 6 (-1)

Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
HFBOT
1
Home Federal Bank of Tennessee
Tennessee
$18.3K – – –
AW
2
Atlas Wealth
Ohio
$4.87K – – –
LIA
3
LBMC Investment Advisors
Tennessee
$4.02K – – –
ACM
4
Academy Capital Management
Texas
$3.66K – – –
FS
5
Financial Symmetry
North Carolina
$1.86K – – –

PVCT Hedge Fund Activity: Q1 2024 in Review

6 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) for Q1 2024, worth a combined $32.7K — up 50% from $21.9K a quarter earlier.

Fund positioning in PVCT was balanced in Q1 2024: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 6 institutional investors held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) as of Q1 2024, down from 7 in Q4 2023.
  • Funds reported $32.7K of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) stock for Q1 2024, up 50% quarter-over-quarter.
  • 0 funds opened new PROVECTUS BIOPHARMACEUTICALS, INC. (DE) positions in Q1 2024 and 0 closed out.

Based on aggregated 13F filings for Q1 2024.